Investment Thesis
ConocoPhillips demonstrates solid revenue growth (13.7% YoY) and healthy operating margins (21.3%), but fundamental concerns exist: net income grew only 0.3% despite strong top-line expansion, diluted EPS fell 18.7%, and free cash flow is deeply negative at -$5.9B. Heavy capital expenditure ($10.2B vs $4.3B operating cash flow) combined with anemic returns on capital (ROE 3.4%, ROA 1.8%) suggest inefficient capital deployment.
Strengths
- Revenue growth of 13.7% YoY demonstrates market demand and pricing power
- Operating margin of 21.3% shows strong operational efficiency and cost management
- Moderate leverage (0.34x debt/equity) provides balance sheet flexibility
Risks
- Negative free cash flow of -$5.9B indicates company is burning cash and dependent on external financing to fund capital programs
- EPS declined 18.7% YoY while net income grew only 0.3% despite 13.7% revenue growth—signals margin compression or elevated costs masking top-line gains
- Severely low returns on capital (ROE 3.4%, ROA 1.8%) suggest capital is being deployed into low-return projects or earnings quality is deteriorating
- Interest coverage ratio of 2.9x provides minimal cushion; limited room for earnings deterioration or rate increases
Key Metrics to Watch
- Free cash flow trend and whether capex normalizes to sustainable levels relative to operating cash generation
- Net margin trajectory and reasons for disconnect between revenue growth and earnings growth
- Return on invested capital and return on equity—whether current capital projects generate acceptable returns
Financial Metrics
Revenue
15.8B
Net Income
2.2B
EPS (Diluted)
$1.78
Free Cash Flow
-5.9B
Total Assets
122.7B
Cash
5.9B
Profitability Ratios
Gross Margin
N/A
Operating Margin
21.3%
Net Margin
13.9%
ROE
3.4%
ROA
1.8%
FCF Margin
-37.2%
Balance Sheet & Liquidity
Current Ratio
1.29x
Quick Ratio
1.14x
Debt/Equity
0.34x
Debt/Assets
47.4%
Interest Coverage
2.86x
Long-term Debt
22.3B
Disclaimer: This analysis is generated by AI based on publicly available SEC EDGAR filings.
It does not include stock price data and should not be considered financial advice.
All fundamental data is sourced from SEC public domain filings.
Always conduct your own research before making investment decisions.
Data Source: SEC EDGAR |
Analysis Date: 2026-05-06T17:19:12.992145 |
Data as of: 2026-03-31 |
Powered by Claude AI